Metrid

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metrid

Metrid (or its generic equivalent, metronidazole) is an essential prescription medication globally recognized for treating a variety of infections caused by certain types of bacteria and parasites.


Quick Facts

Property Description
Active ingredient Metronidazole
Form Oral tablets, capsules, topical gels, and IV solution
Pharmacological Class Nitroimidazole Antimicrobial
Primary Actions Antibiotic and Antiprotozoal
Rx Status Prescription Only (Rx)

Understanding the Medicine

The core of Metrid is the compound metronidazole, which belongs to the class of nitroimidazole antimicrobials. This means the drug is designed to specifically fight infections caused by two primary groups of organisms: anaerobic bacteria (bacteria that thrive without oxygen) and protozoa (single-celled parasites).

Metronidazole’s effectiveness has been clinically recognized by the World Health Organization (WHO), leading to its inclusion on the WHO Model List of Essential Medicines since 1977. This listing confirms its status as one of the safest and most effective medicines needed in a basic health system.

Pharmacological studies strongly support metronidazole's crucial role as a foundational treatment for a broad spectrum of serious conditions, including those in the central nervous system, abdomen, and pelvis. Its ability to target both anaerobic bacteria and protozoa also makes it a primary choice for treating common parasitic conditions like giardiasis and amebiasis. Metrid is only available by prescription and must be used as directed by a healthcare professional.

Regulatory References

  1. protozoa
  2. WHO Model List of Essential Medicines
  3. NIH, Metronidazole (2021)
  4. giardiasis and amebiasis

What side effects are possible with Metrid?

Possible Side Effects and Safety Information

The official safety profile for Metrid (metronidazole) details adverse reactions using classifications based on frequency and affected body system, as documented by regulatory authorities. This profile helps distinguish between common, less severe effects and rare, clinically serious ones.

Frequency-Classified Adverse Reactions

The most frequently reported effects are classified as Very Common or Common in regulatory labeling. Very Common reactions (ge 1/10) include the perception of a metallic taste (dysgeusia). Common reactions (ge 1/100 to < 1/10) typically involve the gastrointestinal system, such as nausea, vomiting, and diarrhea, along with neurological effects like headache and dizziness.

Reactions categorized as Rare or Very Rare include serious risks, such as severe blood disorders (e.g., agranulocytosis) and severe organ system injury.

System-Organ Classes and Serious Reactions

Adverse effects are systematically grouped in official documents:

  • Gastrointestinal Disorders include abdominal pain, glossitis, and stomatitis.
  • Nervous System Disorders are noted for headache, dizziness, and the more serious but rare occurrences of seizures or encephalopathy.
  • Hepatobiliary Disorders involve elevated liver enzymes, jaundice, and rare cases of acute liver failure, sometimes requiring liver transplantation.

The regulatory profile highlights specific safety considerations. The risk of peripheral neuropathy is officially linked to prolonged administration or high doses of the medication. Furthermore, a constraint is placed on the use of the medicine in individuals with severe hepatic impairment due to the potential for the drug to accumulate and cause severe hepatotoxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented manifestations of metronidazole (Metrid) overdose and the regulator-mandated emergency actions. The information is derived strictly from government regulatory documentation.

Overdose presentations, which have been reported following large single oral doses, primarily involve the gastrointestinal system and the central nervous system (CNS).

Documented Manifestations

  • Gastrointestinal: Nausea and vomiting.
  • Neurological: Lack of voluntary coordination, specifically ataxia.

More severe neurological findings, including seizures (convulsions) and peripheral neuropathy (a type of nerve damage), have been reported, particularly in cases associated with very high-dose or extended-duration exposure. These are considered serious outcomes documented in the context of excessive exposure.

Required Emergency Action

The official guidance mandates that immediate medical attention must be sought if an overdose is suspected. Contact emergency services or a poison control center at once.

Treatment of metronidazole overdose is officially required to consist of symptomatic and supportive therapy. This approach is necessary because regulatory information states that no specific antidote is known for metronidazole. Therefore, emergency medical care is essential to manage presenting symptoms and support vital functions until the drug is eliminated.

Therapeutic Uses of Metrid

What Metrid Treats: Main Uses and Benefits

Metrid (generic name: metronidazole) is a medication used to help manage a range of infections caused by certain susceptible bacteria and protozoa. It is a therapy intended to relieve discomfort and assist in controlling the underlying infectious process in common clinical scenarios.

The conditions for which Metrid is commonly used include, but are not limited to, urogenital infections like symptomatic and asymptomatic trichomoniasis, amebiasis (acute intestinal and liver abscess), giardiasis, and infections caused by anaerobic bacteria in areas such as the abdomen and pelvis.

The core benefit to the patient is assistance in reducing symptoms such as discharge and irritation, which may promote comfort and support the return to baseline health. This medication is reserved for use when the presence of the susceptible organism has been confirmed. The safety profile and therapeutic applications are documented in clinical literature.

“The medication is intended to assist in managing the condition, which may help provide symptom relief.”


Quick Fact: Relief for Genital Discomfort (associated with susceptible protozoal and bacterial infections)

Eligibility and Restrictions for Use

Who Can and Cannot Use Metrid (Metronidazole)

The eligibility for using Metrid is strictly defined by regulatory authorities based on a patient's medical history, physiological state, and concurrent substance use. Use is absolutely contraindicated in patients with a known hypersensitivity to metronidazole or other related nitroimidazoles. It must not be used by patients who have taken the drug Disulfiram within the last two weeks, nor is it permitted for those with Cockayne Syndrome due to the risk of severe liver failure.

Use Restrictions and Cautions

Population Group Regulatory Status and Limitation
Alcohol Consumption Contraindicated during therapy and for a specified time afterward.
Severe Hepatic Impairment Conditional use only; requires a mandated dose reduction and close monitoring due to impaired clearance.
Pregnancy Not recommended during the first trimester; use in later trimesters is permitted when clearly necessary.
Breastfeeding Restricted use; temporary cessation of nursing may be advised after single high-dose regimens.
Age Groups Caution is advised for newborns and older adults due to potential diminished organ function or clearance capacity.

Eligibility is conditional for patients with a history of blood dyscrasias or active Central Nervous System (CNS) diseases, requiring caution and continuous monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of metronidazole is formally documented by regulatory authorities to include mandatory restrictions and significant pharmacokinetic alterations with specific substances. These interactions are categorized as contraindicated combinations, exposure-altering pharmacokinetic effects, and pharmacodynamic intolerance reactions.


Contraindicated Combinations and Timing Rules

Metronidazole is officially contraindicated for use with Disulfiram if taken within the preceding two weeks due to the documented risk of psychotic reactions. The consumption of Alcohol (Ethanol) and products containing Propylene Glycol is also contraindicated during therapy and must be avoided for at least three days (72 hours) following the final dose, due to the risk of a formal disulfiram-like reaction.

Documented Exposure-Altering Interactions

Co-administration with Metrid can alter the plasma concentrations of other medicines, which is an interaction pattern classified as pharmacokinetic modification. For example, metronidazole potentiates the anticoagulant effect of Warfarin and other coumarin anticoagulants, resulting in a prolongation of prothrombin time.

Metronidazole exposure itself is increased when co-administered with Cimetidine, which reduces metronidazole's clearance. Conversely, Phenytoin and Phenobarbital are documented to accelerate metronidazole metabolism, resulting in a reduced metronidazole half-life.

Population-Specific Notes

The regulatory profile notes that patients with severe hepatic impairment metabolize metronidazole slowly, causing the accumulation of metronidazole in the plasma. This condition increases the intrinsic risk associated with drug interactions.

Mechanism of Action

Reductive Activation and Mechanism of Action

The mechanism of Metrid is defined by its selective activation within an environment that contains little to no oxygen. The parent drug is chemically transformed by low-potential electrons, primarily transferred by microbial proteins like ferredoxin, which are abundant in anaerobic bacteria and certain protozoa. This selective process diverts the microbe's energy flow to activate the drug, which supports the mechanism's specificity toward the target organism.

Once activated, the drug forms highly reactive, short-lived cytotoxic free radicals that immediately attack vital cellular components. The primary target is the pathogen's DNA, where the radicals cause strand breaks and chemical damage through covalent binding. This mechanism rapidly halts DNA synthesis and compromises the integrity of the microbe's genetic code, leading to the cessation of cell viability due to the irreversible damage.

This efficacy is constrained by the need for an anaerobic environment; high concentrations of oxygen in host tissues compete for the activating electrons, which prevents the activation of the drug's mechanism in aerobic systems. This physiological constraint defines the limits of the drug's mechanism.

Dosage and Administration Information

How Metrid is Used: Standard Administration Guidelines

Metrid (metronidazole) is administered according to standardized protocols to ensure consistent application. Its usage patterns are highly dependent on the formulation and the clinical context for which it is prescribed.

Routes and Forms

Metronidazole is available for oral, intravenous (IV), and topical/vaginal administration. The oral forms include immediate-release tablets, capsules, and extended-release tablets, which differ significantly in how they must be taken.


Standard Dosing and Administration Context

Usage Aspect Administration Principle
Dosing Range Adult dosing for established infections often involves a loading dose of 15 mg/kg followed by maintenance doses of 7.5 mg/kg administered multiple times per day. Certain regimens for trichomoniasis specify a single 2-gram oral dose.
Frequency Pattern Dosing schedules are typically three times daily (TID) or every 6 to 8 hours. The intravenous solution is required to be administered by infusion over 30 to 60 minutes.
Food Relationship Immediate-release tablets may be taken with food to minimize discomfort. Extended-release tablets must be taken on an empty stomach and must not be crushed or broken.
Duration The standard course for many bacterial infections is typically 7 to 10 days, although shorter or single-dose regimens are specified for certain protozoal conditions.

Population-Specific Adjustments

Clinical guidelines specify dose modification for patients with specific physiological conditions. For example, the dosage for patients with severe hepatic impairment (Child-Pugh C) should be reduced by 50% due to the drug's metabolism. Furthermore, dose supplementation may be required following hemodialysis as the procedure partially removes the compound from the system.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Metrid

Evidence for Use in Anaerobic Bacterial Infections

Research concerning Metrid's use for infections caused by anaerobic bacteria—organisms that do not require oxygen to thrive—includes many studies spanning several decades. This research base consists of short-term Randomized Controlled Trials (RCTs) and meta-analyses that compared Metrid's use against other antimicrobial regimens or placebo controls. Researchers monitored outcomes related to the defined endpoint of clinical cure, which is assessed by the change in noticeable symptoms, and microbiological eradication, which is an endpoint that assesses the clearance of the targeted organism from the body. Data show patterns related to how symptoms evolved in the observed populations, which are summarized in the research reviewed by major health authorities.


Evidence for Use in Protozoal Infections

Metrid was studied for its use against infections caused by single-celled parasites, specifically trichomoniasis, amebiasis, and giardiasis. For these conditions, the evidence primarily comes from RCTs and systematic reviews focusing on outcomes related to physical discomfort and parasitological health. Studies monitored two main outcomes: the defined endpoint of parasite clearance and the assessment of symptom change.

For trichomoniasis, research explored short-term symptom changes and examined patient-reported outcomes describing perceived discomfort. For amebiasis, studies focused on acute changes, examining outcomes related to symptomatic relief and monitoring for clearance of the organism from the gut. Continued research is ongoing to fully understand the impact of emerging resistance patterns and to compare results against other specific treatment options.


What Is Still Uncertain About Metrid Research

The research provides context but not individual predictions, and evidence highlights what is known—and what is still uncertain. Long-term effects are not fully established across all indications, especially concerning the prevention of late recurrence or the monitoring of functional outcomes many months or years after treatment. Comparative evidence is lacking in some contexts, meaning that data comparing Metrid directly to some of the newest alternative treatments are not widely available in the current literature. While research has explored short-term changes, data for specific subgroup findings are uncertain.

Key Studies & References

  1. WHO Model List of Essential Medicines (23rd List, 2023) - Metronidazole Inclusion
  2. National Institutes of Health (NIH) - Metronidazole Drug Information and Clinical Use Summary

Frequently Asked Questions (FAQ)

Common questions about Metrid (FAQ)

Q: What happens if I forget to take a scheduled dose of Metrid?

According to the official patient instructions, if a dose is missed, guidance indicates taking it as soon as it is remembered. However, if it is almost time for your next scheduled dose, guidance advises skipping the missed one entirely. It is important to never take two doses at the same time to make up for a dose you forgot.

Q: Are there any known drug interactions between Metrid and common over-the-counter pain relievers?

Official drug interaction data indicates that common pain relievers like acetaminophen generally have no major reported interactions with Metrid. However, Metrid carries a risk of liver effects, and caution is advised when taking it with any other product that also carries a risk of liver injury. Official patient guidance recommends disclosing all medicines and supplements to the prescribing professional.

Q: Is Metrid habit-forming or addictive?

Official regulatory bodies have classified Metrid as a prescription-only medication. It is a type of antimicrobial and is not listed as a Schedule I, II, III, IV, or V controlled substance by agencies such as the DEA. Therefore, it is not considered to be habit-forming.

Q: Does Metrid impact blood pressure?

Metrid is not typically associated with primary effects on blood pressure. However, official safety warnings describe a dangerous disulfiram-like reaction if the medication is combined with alcohol, and this severe reaction has been associated with symptoms including low blood pressure (hypotension).

Q: What is the purpose of the different strengths Metrid is available in?

Official prescribing information indicates that Metrid is available in multiple strengths and forms (like tablets or IV solution). This variety allows the medicine to be precisely dosed for a broad range of clinical conditions, including different types and severities of bacterial or parasitic infections that require differing schedules.

Q: Is there a maximum duration of time Metrid can be taken?

Treatment with Metrid is generally intended to be short-term, such as for 7 to 10 days. Official safety documents indicate that prolonged courses of the medication are generally avoided due to a cumulative risk of developing nervous system damage. This serious, but rare, risk is described as peripheral neuropathy.

Q: Does Metrid interact with birth control pills?

Official drug interaction data indicates that Metrid may reduce the effectiveness of birth control pills that contain the ingredient ethinyl estradiol. Regulatory guidance indicates that patients should discuss the need for additional or alternative non-hormonal contraception with a healthcare provider.

Q: Is Metrid available as a brand-name drug only?

No, Metrid is a brand name for the generic active ingredient, metronidazole. The active ingredient is widely available as a generic medication, and it is considered therapeutically equivalent to the brand-name product by regulatory authorities.

Q: Can Metrid cause changes in mood or behavior?

While uncommon, official regulatory documents have reported rare and serious nervous system disorders such as encephalopathy and psychotic reactions. These serious effects can involve changes in mood, behavior, and overall mental state.

Q: Does Metrid have contraindications for people with a history of heart conditions?

Official contraindications do not list heart conditions as an absolute restriction on its use. However, caution is advised for patients with pre-existing cardiac conditions. This is because the drug, especially when interacting with alcohol, has been associated with heart-related symptoms such as palpitations or arrhythmias.

Q: Is Metrid a controlled substance?

Regulatory bodies classify Metrid as a prescription-only medicine that does not require the additional controls associated with scheduled narcotics. It is an antimicrobial and is not listed as a Schedule I, II, III, IV, or V controlled substance by agencies like the DEA.

Q: What are the non-drug alternatives to Metrid that research has looked at?

Official research and systematic reviews have explored alternatives to Metrid for certain parasitic infections like trichomoniasis and giardiasis. These alternatives often include other non-nitroimidazole treatments, such as clindamycin or nitazoxanide, for use when Metrid is not considered advisable.

Q: Does Metrid change the results of any laboratory tests?

Yes, official safety information states that Metrid has been shown to potentially interfere with the results of certain blood tests. This includes tests for liver enzymes (AST, ALT), LDH, triglycerides, and glucose. Official information suggests informing laboratory personnel of Metrid use.

Q: How quickly should I expect Metrid to start working?

Studies and patient education information indicate that improvement in symptoms often begins within 1 to 3 days of starting the medication. However, the importance of completing the full course is emphasized, even if you feel better quickly, to ensure the infection is fully cleared.

Q: Can Metrid be taken at night?

Official administration instructions advise spacing doses evenly throughout the day. If you are taking multiple doses daily, one of the scheduled doses can be taken at bedtime.

Q: Will Metrid affect my sleep?

Common side effects noted in official documents include headache and dizziness. In rare cases, more serious nervous system effects, which may include confusion or psychosis, have been reported and could potentially affect sleep.

Q: Is Metrid safe to use in older adults?

Caution is officially advised for use in older adults due to the potential for altered metabolism and reduced organ function. Regulatory guidance suggests that a 7-day treatment course is often preferred over single high doses for this population to reduce the risk of high peak drug concentrations.

Q: What is the difference between Metrid and its generic version?

Metrid is the brand name and metronidazole is the generic active ingredient. The two are considered therapeutically equivalent by regulatory authorities. This means they contain the same active ingredient and are expected to produce the same medical effects.

Q: Can Metrid be used by people with kidney problems?

According to official dosing guidance, decreased kidney function alone typically does not require a dose adjustment because the parent drug is primarily processed by the liver. However, patients who undergo hemodialysis may require dose supplementation following the procedure.

Q: Does taking Metrid affect my ability to drive?

Official patient information notes that Metrid can cause common side effects such as dizziness, or more rare effects like ataxia (loss of coordination) and seizures. Because of these potential nervous system effects, official documentation includes a caution against driving or operating complex machinery if these effects are experienced.

Q: Can I stop taking Metrid once I feel better?

Official patient education highlights the need to complete the full course as prescribed. This step is necessary to ensure the infection is fully treated and to help prevent the development of drug-resistant bacteria or parasites.

Q: Are children allowed to take Metrid?

Yes, regulatory documents confirm that Metrid is approved for use in both adults and children. The specific dose administered is adjusted according to the child's weight and the specific type and severity of the infection being treated.

Q: Is it possible to become resistant to the effects of Metrid over time?

Studies and official research summaries confirm that resistance has been observed in clinical isolates, particularly for certain protozoal infections like Trichomonas vaginalis. Failure to clear an infection after standard treatment may be a sign of resistance.

Q: What happens to Metrid in the body after it is taken?

Official pharmacokinetics data indicates that Metrid is processed extensively by the liver. The compound, along with its metabolites, is then primarily eliminated from the body through the urine, accounting for 60% to 80% of the total dose.

Q: Are there specific symptoms that signal a need to stop taking Metrid immediately?

Yes, official safety profiles list severe reactions that require immediate attention. These include signs of liver problems (yellowing of skin/eyes), symptoms of meningitis (stiff neck, confusion), or severe allergic reactions (swelling, difficulty breathing). Regulatory safety profiles describe these symptoms as requiring immediate medical evaluation.

How should Metrid be stored and disposed of?

Storage and Disposal Requirements for Metronidazole (Metrid)


Storage Conditions

Metronidazole tablets and capsules must be stored at Controlled Room Temperature, defined as 20 to 25C (68 to 77F), with excursions permitted up to 30C. The medication must be protected from light and kept in a tight, light-resistant container as required by regulatory labeling. It is mandatory to keep the product out of the sight and reach of children.

Metronidazole injection solutions must be kept in their original outer carton and must not be frozen.


Disposal Instructions

Metronidazole is not on the list of medicines the FDA recommends for flushing. Unused or expired medication should be disposed of using a drug take-back program as the preferred option. If a take-back program is unavailable, the alternative is to mix the medicine with an undesirable substance (such as dirt) in a sealed container and place it in the household trash, avoiding disposal in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Metrid found in:

A-Z Index: